These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29128931)

  • 1. Universal determination of microsatellite instability using BAT26 as a single marker in an Argentine colorectal cancer cohort.
    González ML; Causada-Calo N; Santino JP; Dominguez-Valentin M; Ferro FA; Sammartino I; Kalfayan PG; Verzura MA; Piñero TA; Cajal AR; Pavicic W; Vaccaro C
    Fam Cancer; 2018 Jul; 17(3):395-402. PubMed ID: 29128931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of MT1XT20 Single Quasi-Monomorphic Mononucleotide Marker for Characterizing Microsatellite Instability in Persian Lynch Syndrome Patients.
    Farahani N; Nikpou P; Emami MH; Hashemzadeh M; Zeinalian M; Shariatpanahi SS; Salehi R
    Asian Pac J Cancer Prev; 2016; 17(9):4259-4265. PubMed ID: 27797228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability in young patients with mucinous colorectal cancers - characterization using molecular testing, immunohistochemistry, and histological features.
    Mathews NS; Masih D; Mittal R; Perakath B; Sakthi D; Rebekah G; Pai R; Pulimood AB
    Indian J Cancer; 2019; 56(4):309-314. PubMed ID: 31607698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
    van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
    J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.
    Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X
    Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay.
    Esemuede I; Forslund A; Khan SA; Qin LX; Gimbel MI; Nash GM; Zeng Z; Rosenberg S; Shia J; Barany F; Paty PB
    Ann Surg Oncol; 2010 Dec; 17(12):3370-8. PubMed ID: 20703819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
    Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
    Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of each Bethesda marker in defining microsatellite instability when screening for Lynch syndrome.
    Sinn DH; Chang DK; Kim YH; Rhee PL; Kim JJ; Kim DS; Park CK; Kim JW; Yun SH; Lee WY; Chun HK; Rhee JC
    Hepatogastroenterology; 2009; 56(91-92):672-6. PubMed ID: 19621678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified MSI marker panel for diagnosis of colorectal cancer.
    Shemirani AI; Haghighi MM; Zadeh SM; Fatemi SR; Taleghani MY; Zali N; Akbari Z; Kashfi SM; Zali MR
    Asian Pac J Cancer Prev; 2011; 12(8):2101-4. PubMed ID: 22292659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Lynch Syndrome in Young Colorectal Cancer Patients from Saudi Arabia Using Microsatellite Instability as the Initial Test.
    Alqahtani M; Grieu F; Carrello A; Amanuel B; Mashour M; Alattas R; Alsaleh K; Alsheikh A; Alqahtani S; Iacopetta B
    Asian Pac J Cancer Prev; 2016; 17(4):1917-23. PubMed ID: 27221876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.
    Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK
    Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas.
    Boissière-Michot F; Frugier H; Ho-Pun-Cheung A; Lopez-Crapez E; Duffour J; Bibeau F
    Virchows Arch; 2016 Aug; 469(2):135-44. PubMed ID: 27220764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression.
    Dietmaier W; Wallinger S; Bocker T; Kullmann F; Fishel R; Rüschoff J
    Cancer Res; 1997 Nov; 57(21):4749-56. PubMed ID: 9354436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
    J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases.
    Warth A; Körner S; Penzel R; Muley T; Dienemann H; Schirmacher P; von Knebel-Doeberitz M; Weichert W; Kloor M
    Virchows Arch; 2016 Mar; 468(3):313-9. PubMed ID: 26637197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer.
    Siraj AK; Prabhakaran S; Bavi P; Bu R; Beg S; Hazmi MA; Al-Rasheed M; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS
    Cancer; 2015 Jun; 121(11):1762-71. PubMed ID: 25712738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability of each tumor in sporadic synchronous multiple colorectal cancers.
    Abe Y; Masuda H; Okubo R
    Oncol Rep; 2001; 8(2):299-304. PubMed ID: 11182044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.